An epidemiologist who has speculated about whether there is a connection between Covid-19 vaccines and "turbo cancer" in young people, and works as chief epidemiologist at a company that sells ivermectin alongside reviews that claim it has efficacy as a cancer treatment, has been appointed by president Donald Trump to a key position overseeing the National Cancer Program. Harvey Risch, a professor emeritus of epidemiology at the Yale School of Public Health, announced his appointment as chair of the President's Cancer Panel on X earlier this month.
Dr. Ralph Lee Abraham, the Louisiana surgeon general who halted his state's vaccine promotion campaigns and delayed warning the public about a deadly whooping cough outbreak, has quietly been installed as the second-highest official at the Centers for Disease Control and Prevention. The Department of Health and Human Services did not announce this appointment. The news was first spotted by Dr. Jeremy Faust, who runs the Substack called Inside Medicine.
While this drug is best known as a horse de-wormer, it is also used to treat humans for a variety of conditions and many medications are used to treat conditions they were not originally intended to treat. Viagra is a famous example of this. As such, the idea of re-purposing a medication is not itself foolish. But there are obvious problems with taking ivermectin to treat COVID.